WINDTREE THERAPEUTICS INC /DE/
Datakwaliteit: 83%
WINT
OTC
Manufacturing
Chemicals
€ 0,01
▲
€ 0,00
(20,00%)
Marktkapitalisatie: 394.392,0
Prijs
€ 0,01
Marktkapitalisatie
394.392,0
Dagbereik
€ 0,01 — € 0,01
52-Weeksbereik
€ 0,01 — € 1,86
Volume
95.058
Openen € 0,01
50D / 200D Gem.
€ 0,01
1,69% above
50D / 200D Gem.
€ 0,19
93,65% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -15,12 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROIC-519,54%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio0,33
Interest Coverage-68,64
Waardering
PE (TTM)
-0,01
Boven sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,0 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -39,99 M |
| ROE | N/A | ROA | -167,31% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -15,12 M |
| ROIC | -519,54% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,33 |
| Interest Coverage | -68,64 | Asset Turnover | N/A |
| Working Capital | -14,70 M | Tangible Book Value | -11,61 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,01 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -3834,00% | ||
| Market Cap | 394.392,0 | Enterprise Value | 190.392,0 |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | -0,46 | OCF / Share | -0,46 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 37,81% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -1,79 M | -20,29 M | -39,21 M | -67,64 M | -32,57 M |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -26,14 M | -20,60 M | -41,33 M | -77,28 M | -30,32 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 16,28 M | 8,34 M | 11,10 M | 17,79 M | 15,37 M |
| SG&A Expenses | 8,74 M | 9,20 M | 10,79 M | 14,47 M | 14,94 M |
| D&A | — | — | — | — | — |
| Interest Expense | 235.000,0 | 50.000,0 | 53.000,0 | 114.000,0 | 125.000,0 |
| Income Tax | -6.000,0 | 0,0 | -1,37 M | -9,99 M | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 27,88 M | 32,41 M | 37,95 M | 74,79 M | 112,89 M |
| Total Liabilities | 14,70 M | 29,02 M | 27,94 M | 32,91 M | 43,33 M |
| Shareholders' Equity | 10,00 M | 3,39 M | 10,01 M | 41,88 M | 69,55 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 1,78 M | 4,32 M | 6,17 M | 22,35 M | 16,93 M |
| Current Assets | 2,57 M | 5,38 M | 7,38 M | 23,49 M | 18,12 M |
| Current Liabilities | 5,72 M | 4,00 M | 2,46 M | 4,92 M | 6,13 M |
{"event":"ticker_viewed","properties":{"ticker":"WINT","listing_kind":"stock","pathname":"/stocks/wint","exchange":"OTC","country":"US"}}